期刊文献+

血管阻断剂活性化合物AVE-8063的合成

A Simple and Efficient Method for the Synthesis of Vascular Disrupting Agent AVE-8063
下载PDF
导出
摘要 对血管阻断剂活性分子(Z)-3'-氨基-3,4,4',5-四甲氧基二苯乙烯(AVE-8063)的合成进行了研究。以对甲氧基苯乙酸(Ⅰ)为原料,经溴代及Perkin反应得到(E)-2-(3-溴-4-甲氧基苯基)-3-(3,4,5-三甲氧基苯基)丙烯酸(Ⅲ),再经芳环上溴的氨基取代得到(E)-2-(3-氨基-4-甲氧基苯基)-3-(3,4,5-三甲氧基苯基)丙烯酸(Ⅳ),最后在Cu/1,10-Phen/PEG-400体系微波辅助下反应6 min即脱羧得到目标化合物(Ⅴ),总收率为60.1%。产物结构经IR、MS和1HNMR确证。 A new synthetic protocol leading to the vascular disrupting agent (Z)-3'-amino-3,4,4', 5- tetramethoxylstilbene ( AVE - 8063 ) was successfully devised. Starting from 4-methoxyphenylacetic acid, (E) -2- ( 3-bromo-4-methoxyphenyl ) -3- ( 3,4,5-trimethoxyphenyl ) acrylic acid ( m ) could readily be obtained through bromination and Perkin condensation. Amination of ]U afforded (E)-2-( 3-animo- 4-methoxyphcnyl)-3-( 3, 4, 5-trimethoxyphenyl )acrylic acid (IV), which was subsequently decarboxylated in Cu/1,10-Phen/PEG-400 system under microwave conditions for 6 rain to give the target product ( V ) with a total yield of 60. 1%. The structure of the product was verified by IR, MS and 1HNMR.
出处 《精细化工》 EI CAS CSCD 北大核心 2013年第5期549-554,共6页 Fine Chemicals
基金 国家自然科学基金(21272280) 广东省中国科学院全面战略合作项目(2009B091300125) 广东省战略新兴产业核心技术攻关项目(2011A081401002) "十二五"国家重大新药创制项目(2011ZX09202-101-07) 广州市科技计划项目(2012J4300097)~~
关键词 AVE-8063 二苯乙烯类化合物 脱羧 PERKIN反应 血管阻断剂 医药与日化原料 AVE - 8063 stilbenes decarboxylation Perkin reaction vascular disrupting agents drugand cosmetic materials
  • 相关文献

参考文献23

  • 1Lin C M, Pettit G R. Antimitotic natural-products combretastatinA -4 and Combretastatin A - 2 :studies on the mechanism of theirinhibition of the binding of colchicine to tubulin[ J]. Biochemistry,1989,28(17) :6984 -6991.
  • 2Kanashiro A,Lucisano-Valim Y M. Sesquiterpene lactones fromLychnophora pohiii : neutrophil chemiluminescence inhibition andfree radical scavenger activity [ J ]. J Pharm Pharmacol,2006,58(6) :853 -858.
  • 3Ververidis F,Trantas E,Kretzschmar G,et al. Biotechnologyof flavonoids and other phenylpropanoid-derived natural products.Part I : Chemical diversity,impacts on plant biology and humanhealth [J]. Biotechnol J, 2007 ’2:1214 - 1234.
  • 4Tozer G M,Kanthou C,Baguley B C. Disrupting tumour bloodvessels[ J]. Nat Rev Cancer,2005 ,5 :423 -435.
  • 5Hori K,Saito S. Microvascular mechanisms by which thecombretastatin A-4 derivative AC7700 ( AVE8062) induces tumourblood flow stasis [ J ] . British Journal of Cancer,2003 ,89 (7) : 1334-1344.
  • 6Hatanaka T,Ohsumi K,Tsuji T,ef al. Stilbene compounds andpharmaceutical compositions containing them [ P]. US: 5674906 ,1997 -10 -07.
  • 7Yamamoto T,Matsueda H,Naito M. Process for preparingaminostilbene derivatives[ P]. US :6930205B2,2005 -08 -16.
  • 8Pinney K G,Mejia M P. Synthesis and biological evaluation of arylazide derivatives of combretastatin A - 4 as molecular probes fortubulin[ J]. Bioorg Med Chem,2000,8:2417 -2425.
  • 9Ohsumi K,Nakagawa R,Fukuda Y,et al. Novel combretastatinanalogues effective against murine solid tumors: Design andstructure-activity relationships[ J]. J Med Chem, 1998 ,41 :3022 ~3032.
  • 10甄永刚,邹永.血管阻断剂(Z)-2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙烯基]-苯胺的合成[J].精细化工,2007,24(4):372-375. 被引量:1

二级参考文献25

  • 1F Jafarpour, N Jalalimanesh, M B A Olia et al. Tetrahedron, 2010, 66:9508 -9511.
  • 2P FLu, Sanchez C, Cornelia J et al. Org. Lett. , 2009, 11(24) : 5710 -5713.
  • 3C Anurag, S N Pandeya, P Kumar et al. Med. Chem. , 2007, 7(12) :1186 -1205.
  • 4L K Folkes, M Christlieb, E Madej et al. Chem. Res. Toxicol. , 2007, 20 (12) : 1885 -1894.
  • 5N H Nam. Curt. Med. Chem., 2003, 10(17): 1697 -1722.
  • 6H Matsuda, S Tewtrakul, T Morikawa et al. Bioorg. Med. Chem. , 2004, 12(18) : 4871 -4876.
  • 7X L Meng, J Y Yang, G L Chen et al. Chemico-Biological Interactions, 2008, 174(1) : 51 -59.
  • 8D Simoni, M Roberti, F P Invidiata et al. Bioorg. Med. Chem. Lett. , 2006, 16(12) : 3245 -3248.
  • 9M Tolomeo, S Grimaudo, A Di Cristina et al. Int. J. Biochem. Cell Biol. , 2005, 37(8) : 1709 -1726.
  • 10A F Shepard, N R Wilson, J R Johnson. J. Am. Chem. Soc. , 1930, 52(5) : 2083 -2090.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部